Carter v. Superior CourtCarter v. Superior Court
Opinion
INTRODUCTION
Robert Carter, a criminal defendant facing violent felony charges, was found incompetent to stand trial. The trial court then authorized a state hospital to administer antipsychotic drugs against his will in an effort to restore his competency. Under
Sell v. United States
(2003)
FACTUAL AND PROCEDURAL BACKGROUND
Petitioner was charged with rape, sexual battery, assault with a deadly weapon, and false imprisonment. At
Supplemental reports were submitted by both doctors. Dr. Rothberg again concluded petitioner was incompetent to stand trial. He wrote: “It is medically appropriate that [petitioner’s] psychiatric condition be treated with medication. This anti-psychotic medication is likely to be effective. [Petitioner] lacks the capacity to make decisions about such medication, and he will have to be medicated involuntarily in all likelihood. If untreated with medication, he will suffer serious harm to his physical and mental health. [Petitioner] is suffering from schizophrenia and experiences numerous delusional ideas which impairs his thinking, his ability to interact with others and to function in an effective manner. He is highly paranoid and is very likely to deteriorate further in the absence of appropriate aggressive treatment with such medication.” Dr. Rothberg further concluded, “Treatment with antipsychotic medication is very likely to render [petitioner] competent to stand trial. However, there are potential side effects. Such medications are listed in the
Dr. Miles wrote in his report that petitioner exhibited “expansive mood and grandiose delusions, consistent with possible diagnoses of delusional disorder, schizoaffective disorder, and bipolar disorder with psychosis.” He further stated, “Psychological testing may provide data to assist in the differential diagnosis, [f] As a result of his mental disorder, he does not appear to appreciate the nature and purpose of proceedings against him. Thus, he does not appear to be competent at this time. [][] If [petitioner] is suffering from bipolar disorder or schizoaffective disorder, medication may reduce symptomology to the point where he could become competent. ... If his case is sufficiently important, as it appears to be, [in]voluntary administration of medication to restore competency would be reasonable if the diagnosis after psychological testing is one[] [wjhich responds to medication.”
At the next hearing, petitioner’s attorney argued the two doctor reports were insufficient to support involuntarily medicating petitioner. Counsel specifically noted neither report indicated a clear and specific diagnosis of petitioner’s mental condition; the reports also failed to specify the medication that would be administered to petitioner, or the potential side effects. The trial court continued the hearing and ordered Drs. Rothberg and Miles to supplement their reports by completing the standard form “used in mental health court Department 95 specifying data that appointed experts must provide when the court has declared a doubt about a defendant’s competence to stand trial.”
In response, Dr. Rothberg submitted a letter indicating his report already addressed all the pertinent Sell factors. Dr. Miles returned the court’s mental health form. Dr. Miles answered “maybe” to the following questions: (1) whether it would be medically appropriate to treat petitioner with medication, (2) whether medication would be effective, (3) whether the medication would make petitioner competent to stand trial, and (4) whether if left untreated petitioner would suffer serious harm to his physical or mental health. He further stated petitioner did not have the capacity to make decisions about his medication and was not dangerous to others or to himself in his current setting. Dr. Miles indicated any potential side effects from “such medication” could be found in the Physicians’ Desk Reference, and that “such medication” was unlikely to have side effects that interfere with petitioner’s ability to understand the nature of the criminal proceedings or assist counsel in his defense. When asked whether less intrusive treatments were unlikely to have substantially the same results as medication, Dr. Miles responded by placing a question mark on the form.
Finally, Dr. Miles concluded, “If [petitioner] suffers from delusional disorder[,] medication is not likely to be effective. If he suffers from schizoaffective disorder or bipolar disorder with psychosis, it is likely to be effective. Further evaluation, including psychological testing[,] should be obtained to determine if medication is appropriate and likely to be effective.”
At the competency hearing, petitioner’s counsel again argued the reports submitted by Drs. Rothberg and Miles were insufficient under
Sell.
The court disagreed and specifically found “important governmental
Petitioner filed a writ petition challenging the trial court’s medication order and asking that the order be stayed pending our decision. Petitioner argued the evidence was insufficient to justify involuntary administration of antipsychotic drugs. We stayed the court’s order and asked the People to file a response.
In keeping with its practice generally throughout the proceedings, the district attorney’s office filed a letter brief in which it stated the People were not taking a position on the issue of involuntary medication. We issued an order indicating our intention to grant the petition and issue a peremptory writ of mandate in the first instance. (See
Palma v. U.S. Fasteners, Inc.
(1984)
DISCUSSION
1. Constitutional and Statutory Law Pertaining to Involuntary Medication
In a series of cases over the last 16 years, the United States Supreme Court has recognized that an individual has a constitutionally protected liberty interest under the due process clause of the Fourteenth Amendment to refuse administration of antipsychotic medication. In
Washington
v.
Harper
(1990)
The liberty interest recognized by the Supreme Court is grounded in two considerations. “First, the drugs ‘tinker[] with the mental processes,’ [citation], affecting cognition, concentration, behavior, and demeanor. While the resulting personality change is intended to, and often does, eliminate undesirable behaviors, that change also, if unwanted, interferes with a person’s self-autonomy, and can impair his or her ability to function in particular contexts.”
(U.S.
v.
Williams
(9th Cir. 2004)
The most recent iteration of the rule is found in
Sell.
There, the Supreme Court expanded on its
Harper
and
Riggins
precedents and held the government could involuntarily administer antipsychotic drugs on a mentally ill criminal defendant in order to render him competent to stand trial only if four factors were present: “(1)
‘important
governmental interests are at stake’; (2) involuntary medication will
‘significantly further’
the concomitant state interests of timely prosecution and a fair trial; (3) ‘involuntary medication is
necessary
to farther those interests’; and (4) ‘administration of the drugs is
medically appropriate
....’”
(People v. O’Dell
(2005)
Although constitutionally permitted, orders for involuntary medication of antipsychotic drugs are disfavored and should be issued only on a compelling showing.
(U.S. v. Rivera-Guerrero
(9th Cir. 2005)
Although California statutory law on the involuntary medication of criminal defendants predates
Sell,
after the Supreme Court issued its opinion, those statutes were amended to meet the constitutional standards.
(O’Dell, supra,
2. The Involuntary Medication Order for Petitioner Was Not Supported by Substantial Evidence
We review for substantial evidence orders authorizing a state hospital to administer antipsychotic medication involuntarily to a criminal defendant.
(O’Dell, supra,
Sell
first requires us to consider whether there is substantial evidence in the record that important governmental interests were at stake.
(Sell, supra,
The only governmental interest identified by the trial court in the present case was “bringing the defendant to trial.” This finding literally satisfies the first element under section 1370, and
Sell
acknowledges that it is an important consideration under the constitutional standard, but “[s]pecial circumstances may lessen the importance of that interest.”
(Sell, supra,
Remarkably, the prosecutor made no effort to claim there was any governmental interest that would be advanced by subjecting petitioner to involuntary antipsychotic medication. The prosecutor remained silent throughout the trial court proceedings and took no position on the issue of petitioner’s mental competency or the appropriateness of involuntary medication. We asked the People to file a response to petitioner’s writ petition and received a letter by which they continue to take no position on the issue of involuntary medication. Given that three of the four Sell factors require the consideration and balancing of “important governmental interests,” it is difficult to conceive of a situation where the trial court will have a complete, fair, and reliable record upon which to make its involuntary medication determination without input from the government concerning its interests and how those interests may be affected.
Even if the brutal nature of the crimes alleged were themselves sufficient to satisfy the first constitutional and statutory elements, there was an insufficient showing of the existence of the other factors to uphold the court’s order.
Sell
mandates substantial evidence that subjecting an accused to involuntary medication of antipsychotic drugs would significantly further the state interests of timely prosecution and a fair trial. (See
U.S. v. Evans
(4th Cir. 2005)
The only evidence before the trial court regarding this element were the statements of Drs. Rothberg and Miles, and that testimony
The evidence regarding the actual medication petitioner should be given was nonexistent. Dr. Rothberg concluded petitioner should be treated with “antipsychotic medication” and that the medication would likely render him competent to stand trial. Dr. Miles conditioned the effectiveness of antipsychotic medication on petitioner’s suffering from bipolar or schizoaffective disorder; medication would
not
be effective if petitioner had a delusional
disorder. In Dr. Miles’s view, further evaluation and testing would be necessary to determine if involuntarily medicating petitioner would be appropriate and effective. Other than generally referring to “medication,” neither psychiatrist specified which antipsychotic drugs petitioner should be prescribed. This deficiency underscores the constitutional failure. At a
Sell
hearing, “the [trial] court is required to consider specific drugs, their unique side effects, and their medical appropriateness. Specificity as to the medications to be administered is critical.”
(Rivera-Guerrero, supra,
Evidence regarding the potential side effects of particular antipsychotic drugs is similarly absent. Neither Dr. Rothberg nor Dr. Miles articulated any side effects petitioner might reasonably experience if he was forcibly medicated. Their reports simply referred the court to certain general medical publications on the potential side effects of antipsychotic medications generally. These statements were not only unhelpful to the court, but they were wanting under Sell. Without specific information regarding the drugs to be given and possible side effects, there was no evidence to support the psychiatrists’ opinions, or the court’s conclusions, that involuntarily administering such medication was substantially likely to render petitioner competent to stand trial and would not interfere with his “ability to understand the nature of the criminal proceedings or to assist counsel in the conduct of a defense in a reasonable manner.” (§ 1370, subd. (a)(2)(B)(ii)(III).)
Sell
further requires that we consider whether there was substantial evidence that forcibly medicating petitioner was
necessary
to further the governmental interests of timely prosecution and a fair trial. “This third factor in
Sell
corresponds to the fourth factor in section 1370, subdivision [(a)(2)(B)(ii)(III)]. ‘The court must find that any alternative, less intrusive treatments are unlikely to achieve substantially the same results,’ and ‘must consider less intrusive means for administering the drugs,
e.g.,
a court order to the defendant backed by the contempt power . . . .’ [Citation.]”
(O’Dell, supra,
The only information provided by Dr. Rothberg concerning alternatives or less intrusive methods was his conclusory statement that “[l]ess intrusive treatments are unlikely to have substantially the same results as medication.” Alternative treatments were not described, nor was there any explanation of
what results might be expected from such treatments or why those results, while perhaps not the “same,” would not be sufficient to satisfy
The final
Sell
factor is that the administration of antipsychotic medication is in petitioner’s best medical interests in light of his actual condition. “This fourth factor in
Sell
corresponds to the fifth factor in section 1370, subdivision [(a)(2)(B)(ii)(III)]. ‘The specific kinds of drugs at issue may matter here as elsewhere. Different kinds of antipsychotic drugs may produce different side effects and enjoy different levels of success.’ [Citation.]”
(O’Dell, supra,
3. Conclusion
“The importance of the defendant’s liberty interest, the powerful and permanent effects of anti-psychotic medications, and the strong possibility that a defendant’s trial will be adversely affected by the drug’s side-effects all counsel in favor of ensuring that an involuntary medication order is issued only after both sides have had a fair opportunity to present their case and develop a complete and reliable record.”
(Rivera-Guerrero, supra,
Here, important government interests were not fully articulated and the record fell short of meeting the constitutional and statutory requirements. The order was, therefore, not supported by substantial evidence.
DISPOSITION
The petition is granted. The trial court is ordered to (1) vacate its order authorizing petitioner to be involuntarily medicated; (2) if otherwise appropriate given the then-current status of the case, conduct a new hearing on the subject, at which hearing the parties shall be permitted to introduce additional evidence; and (3) determine whether, under the criteria established by Sell and section 1370, antipsychotic medication should be administered to petitioner involuntarily. Our previous stay order is dissolved.
Boland, J., and Flier, J., concurred.
Notes
All further statutory references are to the Penal Code.
While this writ proceeding was pending, petitioner’s counsel informed us that the trial court had granted petitioner’s motion to set aside the information pursuant to section 995. This development renders the petition moot. Nonetheless, we may retain and decide a case even when the particular controversy is technically moot if it concerns important issues of substantial and continuing public interest. (See
Abbott Ford, Inc. v. Superior Court
(1987)
The trial court did not base its decision on the grounds petitioner was a danger to himself or others, or that the treatment was in his best medical interest. We do not address the issue of petitioner’s dangerousness, and we discuss petitioner’s best medical interest only briefly (see p. 1005, post).
Subdivision (a)(2)(B) of section 1370, applicable here because petitioner was charged with felonies, provides, in relevant part: “The court shall hear and determine whether the defendant, with advice of his or her counsel, consents to the administration of antipsychotic medication, and shall proceed as follows: [ffl . . . [1] (ii) If the defendant does not consent to the administration of medication, the court shall hear and determine whether any of the following is true: [f ] . . . [][] (HI) The people have charged the defendant with a serious crime against the person or property; involuntary administration of antipsychotic medication is substantially likely to render the defendant competent to stand trial; the medication is unlikely to have side effects that interfere with the defendant’s ability to understand the nature of the criminal proceedings or to assist counsel in the conduct of a defense in a reasonable manner; less intrusive treatments are unlikely to have substantially the same results; and antipsychotic medication is in the patient’s best medical interest in light of his or her medical condition. [IQ (iii) If the court finds any of the conditions described in clause (ii) to be true, the court shall issue an order authorizing the treatment facility to involuntarily administer antipsychotic medication to the defendant when and as prescribed by the defendant’s treating psychiatrist. The court shall not order involuntary administration of psychotropic medication under sub-clause (HI) of clause (ii) unless the court has first found that the defendant does not meet the criteria for involuntary administration of psychotropic medication under subclause[s (I), (II) of clause (ii) dealing with an inmate’s overall mental health and where he or she is a danger to others].”
We note the first statutory factor does not literally require the trial court to consider “the important governmental interests at stake,” as articulated in Sell. Although it is true that in most instances an important governmental interest will be implicated when the defendant is charged “with a serious crime against the person or property,” we can imagine situations where that might not be the case. Therefore, to the extent a trial court bases its involuntary medication decision strictly upon the first factor under section 1370, subdivision (a)(2)(B)(ii)(III), without considering the broader question of the importance of the governmental interest, the order might not satisfy Sell’s constitutional standard.
Obviously, here the crimes involve a serious and violent attack on a person and hence satisfy the statutory definition.
The “standard form” that the mental health department of the Los Angeles Superior Court uses when it declares a doubt as to a criminal defendant’s competency is not on its own likely to elicit sufficient information regarding the specific antipsychotic drugs that might be administered, the recommended dosage, and the potential side effects of such drugs. It does not ask for any detailed information regarding alternative and less intrusive treatments. Without a separate doctor’s report or an addendum to the form, it is doubtful information on the form could satisfy the Sell criteria.